Abdel-Naser Elzouki Selected Research

Abdel-Naser Elzouki Research Topics

Disease

3	COVID-19 09/2021 - 01/2020
3	Thrombosis (Thrombus) 01/2021 - 01/2020
2	Bacterial Infections (Bacterial Infection) 05/2022 - 03/2019
2	Gastroesophageal Reflux (GERD) 01/2022 - 05/2020
2	Neoplasms (Cancer) 01/2021 - 04/2020
2	Chemical and Drug Induced Liver Injury 01/2021 - 12/2019
2	Infections 01/2021 - 09/2020
2	Fibrosis (Cirrhosis) 12/2020 - 12/2017
2	Venous Thromboembolism 04/2020 - 01/2020
1	Acute Coronary Syndrome 07/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Anemia 01/2021
1	Hypoalbuminemia 01/2021
1	Hemorrhage 01/2021
1	Inflammation (Inflammations) 01/2021
1	Leukocytosis (Pleocytosis) 01/2021
1	Obesity 05/2020
1	Weight Loss (Weight Reduction) 05/2020
1	Pulmonary Embolism 01/2020
1	Disseminated Intravascular Coagulation 01/2020
1	Hepatitis B 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Needlestick Injuries (Needlestick Injury) 01/2020
1	Disease Progression 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 12/2019
1	Hypotension (Low Blood Pressure) 12/2019
1	Fever (Fevers) 12/2019
1	Type 2 Diabetes Mellitus (MODY) 06/2019
1	Peritonitis 03/2019
1	Abdominal Pain (Pain, Abdominal) 01/2019
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2016
1	Hypersensitivity (Allergy) 11/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2016
1	Pouchitis 11/2016
1	Colitis 11/2016
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2016
1	Diarrhea 11/2016
1	Suppuration 07/2014
1	Pyogenic Liver Abscess 07/2014
1	Abscess 07/2014
1	Amebic Liver Abscess 07/2014

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 09/2021 - 12/2019
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 12/2020 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2016 - 07/2014
1	EndotoxinsIBA 05/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022
1	Bile Acids and Salts (Bile Acids)IBA 05/2022
1	BilirubinIBA 05/2022
1	MicroRNAs (MicroRNA)IBA 09/2021
1	Small Nucleolar RNA (snoRNA)IBA 09/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2021
1	TicagrelorIBA 07/2021
1	C-Reactive ProteinIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	RivaroxabanIBA 01/2021
1	ElectrolytesIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Micafungin (FK463)FDA Link 01/2021
1	Complement C5a (Complement 5a)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	ProcalcitoninIBA 01/2021
1	Thyroid HormonesIBA 01/2021
1	Insulin (Novolin)FDA Link 09/2020
1	Factor Xa InhibitorsIBA 04/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	Fibrin Fibrinogen Degradation ProductsIBA 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020
1	Tuberculin (PPD)IBA 01/2020
1	Hepatitis C AntibodiesIBA 01/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2019
1	Triglycerides (Triacylglycerol)IBA 06/2019
1	CholesterolIBA 06/2019
1	Proton Pump InhibitorsIBA 03/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	Amylases FDA Link 01/2019
1	AntibodiesIBA 12/2017
1	Coloring Agents (Dyes)IBA 07/2014
1	Metronidazole (Metric)FDA LinkGeneric 07/2014

Therapy/Procedure

4	Therapeutics 07/2021 - 12/2019
2	Bariatric Surgery 01/2022 - 05/2020
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 05/2020
2	Gastrectomy 01/2022 - 05/2020
1	Percutaneous Coronary Intervention 07/2021
1	Length of Stay 12/2020
1	Polypharmacy 12/2020
1	Drug Therapy (Chemotherapy) 12/2019